Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
37657
CAS Number:
3543-75-7
Hidrato de clorhidrato de bendamustina
Purity:
≥ 98% (ensayo, HPLC)
Synonym(s):
Clorhidrato de ácido 5-[bis(2-cloroetil)amino]-1-metilbencimidazol-2-butírico
Hazmat
Documents
$260.69 /200 mg
Tamaño
Request Bulk Quote
Información del producto

Bendamustine hydrochloride hydrate is a potent chemotherapeutic agent primarily used in the treatment of various hematological malignancies, including chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma. This compound combines the properties of a traditional alkylating agent with those of a purine analog, making it effective in disrupting DNA synthesis and promoting apoptosis in cancer cells. Its unique mechanism of action allows for a more targeted approach, which can lead to improved efficacy and reduced toxicity compared to other chemotherapy agents.

In addition to its applications in oncology, Bendamustine hydrochloride hydrate is also being explored for use in combination therapies, enhancing the effectiveness of existing treatment regimens. Researchers appreciate its versatility in clinical settings, as it can be administered intravenously or orally, providing flexibility in patient care. With ongoing studies investigating its potential in treating other malignancies and its favorable safety profile, Bendamustine hydrochloride hydrate remains a valuable compound in the arsenal against cancer.

Número CAS
3543-75-7
Fórmula molecular
C16H21Cl2N3O2 · HCl · xH2O
Peso molecular
394.72
Número MDL
MFCD16879055
Punto de fusión
165 - 169 ?C
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
3543-75-7
Fórmula molecular
C16H21Cl2N3O2 · HCl · xH2O
Peso molecular
394.72
Número MDL
MFCD16879055
Punto de fusión
165 - 169 ?C
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Bendamustine hydrochloride hydrate is widely utilized in research focused on:

  • Cancer Treatment: Primarily used in oncology, it is effective for treating chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma, providing a targeted approach that minimizes damage to healthy cells.
  • Combination Therapies: Often combined with other chemotherapeutic agents, enhancing the overall efficacy of treatment regimens while potentially reducing side effects compared to traditional chemotherapy.
  • Research in Drug Development: Serves as a model compound in pharmacology studies, helping researchers understand drug interactions and resistance mechanisms in cancer cells.
  • Pharmaceutical Formulations: Used in the development of injectable formulations, allowing for precise dosing and improved patient compliance in clinical settings.
  • Clinical Trials: Frequently involved in clinical research to evaluate new treatment protocols, contributing to advancements in cancer therapy and improving patient outcomes.

Citas